LGT Capital Partners LTD. maintained its position in Cerner Co. (NASDAQ:CERN) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 230,000 shares of the company’s stock at the end of the first quarter. Cerner comprises about 1.5% of LGT Capital Partners LTD.’s holdings, making the stock its 27th largest position. LGT Capital Partners LTD. owned 0.07% of Cerner worth $13,536,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. Advantage Investment Management LLC bought a new position in Cerner during the fourth quarter valued at approximately $103,000. Parallel Advisors LLC bought a new position in Cerner during the fourth quarter valued at approximately $115,000. Hall Laurie J Trustee bought a new position in Cerner during the fourth quarter valued at approximately $119,000. Fuller & Thaler Asset Management Inc. bought a new position in Cerner during the third quarter valued at approximately $124,000. Finally, Blenheim Capital Management BV bought a new position in Cerner during the fourth quarter valued at approximately $126,000. 80.58% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Cerner Co. (NASDAQ:CERN) traded down 0.83% during midday trading on Friday, hitting $58.86. 889,537 shares of the stock traded hands. The company’s 50 day moving average price is $57.50 and its 200-day moving average price is $54.08. The stock has a market cap of $19.41 billion, a price-to-earnings ratio of 31.82 and a beta of 1.05. Cerner Co. has a 12-month low of $47.01 and a 12-month high of $67.50.
Cerner (NASDAQ:CERN) last issued its quarterly earnings results on Thursday, February 9th. The company reported $0.61 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.61. The company had revenue of $1.26 billion for the quarter, compared to analyst estimates of $1.26 billion. Cerner had a net margin of 13.27% and a return on equity of 18.16%. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.61 earnings per share. On average, equities research analysts expect that Cerner Co. will post $2.50 EPS for the current year.
Several research firms have recently commented on CERN. Zacks Investment Research raised shares of Cerner from a “sell” rating to a “hold” rating in a report on Monday, March 20th. Oppenheimer Holdings Inc. reissued a “market perform” rating on shares of Cerner in a report on Friday, February 10th. Stifel Nicolaus boosted their target price on shares of Cerner from $56.00 to $60.00 and gave the stock a “hold” rating in a report on Wednesday, February 22nd. TheStreet raised shares of Cerner from a “c+” rating to a “b-” rating in a report on Monday, April 3rd. Finally, Canaccord Genuity reissued a “buy” rating and issued a $63.00 target price on shares of Cerner in a report on Friday, January 13th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and ten have assigned a buy rating to the company. Cerner currently has a consensus rating of “Hold” and a consensus target price of $62.15.
In other news, VP Jeffrey A. Townsend sold 100,000 shares of the business’s stock in a transaction dated Monday, February 13th. The stock was sold at an average price of $52.31, for a total transaction of $5,231,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Neal L. Patterson sold 20,000 shares of the business’s stock in a transaction dated Tuesday, March 14th. The stock was sold at an average price of $54.91, for a total value of $1,098,200.00. The disclosure for this sale can be found here. 13.20% of the stock is owned by corporate insiders.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Co. and related companies with MarketBeat.com's FREE daily email newsletter.